Latest filing published 08 Dec 2023 for bluebird bio, Inc., €19k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Christopher Krawtschuk: trading record in brief
Christopher Krawtschuk appears in our data through filings on bluebird bio, Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 1 December 2022 and the latest from 6 December 2023.
Every open-market trade on record is a sale: 1 sale worth €19k. Other entries cover 1 share grant. So far in 2023, the count stands at no purchases and 1 sale.
The record was last updated on 8 December 2023 with an open-market sale (€19k) in bluebird bio, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christopher Krawtschuk
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,526 shares@ US$4.5155100.0% of flowCommon StockSEC:0001562180-23-008250:0
- 50,000 shares0Common StockSEC:0001562180-22-008057:0
2 of 2 declarations
